MERS-Co V

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:virus
gptkbp:caused_by Middle East respiratory syndrome
gptkbp:discovered_by gptkb:2012
gptkbp:distribution gptkb:Europe
gptkb:Middle_East
gptkb:Asia
gptkb:North_Africa
gptkb:United_States
gptkbp:end_of_life approximately 34%
gptkbp:family gptkb:virus
gptkbp:genus gptkb:Betacoronavirus
gptkbp:healthcare economic impact
travel restrictions
surveillance measures
global health concern
https://www.w3.org/2000/01/rdf-schema#label MERS-Co V
gptkbp:is_protected_by good hygiene practices
avoid contact with camels
gptkbp:is_recognized_by gptkb:Saudi_Arabia
gptkbp:is_vulnerable_to none available
gptkbp:nutritional_value enveloped
spike protein
gptkbp:related_to gptkb:SARS-Co_V
gptkb:SARS-Co_V-2
gptkbp:research_focus genetic studies
vaccine development
treatment options
transmission dynamics
gptkbp:reservoir dromedary camels
gptkbp:responds_to public health guidelines
monitoring outbreaks
gptkbp:seed_dispersal single-stranded RNA
gptkbp:social_responsibility PCR test
outbreaks
sporadic cases
2015 outbreak in South Korea
2018 outbreak in Saudi Arabia
2019 outbreak in the Middle East
2020 cases reported
2021 cases reported
2022 cases reported
isolation of infected patients
quarantine of contacts
gptkbp:symptoms gptkb:healthcare_organization
cough
fever
shortness of breath
gptkbp:transmission camel-to-human
human-to-human
gptkbp:treatment supportive care
antiviral medications